TANG CAPITAL MANAGEMENT LLC Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$837.0B
Holdings
17
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (17 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | —ODONATE THERAPEUTICS INC | 14,075,269 | $456.7B | 54.57% | |
| 2 | HRTXHERON THERAPEUTICS INC | 5,017,203 | $117.9B | 14.09% | |
| 3 | RCKTROCKET PHARMACEUTICALS INC | 2,965,485 | $67.5B | 8.06% | |
| 4 | RLMDRELMADA THERAPEUTICS INC | 1,300,000 | $50.7B | 6.06% | |
| 5 | EOLSEVOLUS INC | 2,635,000 | $32.1B | 3.83% | |
| 6 | ANABANAPTYSBIO INC | 1,843,814 | $30.0B | 3.58% | |
| 7 | —AVROBIO INC | 1,000,000 | $20.1B | 2.41% | |
| 8 | —LA JOLLA PHARMACEUTICAL CO | 4,938,893 | $19.4B | 2.32% | |
| 9 | REGNREGENERON PHARMACEUTICALS | 45,000 | $16.9B | 2.02% | |
| 10 | BMYBRISTOL MYERS SQUIBB CO | 111,844 | $7.2B | 0.86% | |
| 11 | PRTAPROTHENA CORP PLC | 423,823 | $6.7B | 0.80% | |
| 12 | GTHXEURG1 THERAPEUTICS INC | 170,000 | $4.5B | 0.54% | |
| 13 | PBYIPUMA BIOTECHNOLOGY INC | 349,400 | $3.1B | 0.37% | |
| 14 | OPHTEURIVERIC BIO INC | 250,000 | $2.1B | 0.26% | |
| 15 | —NUCANA PLC | 250,000 | $1.5B | 0.18% | |
| 16 | BMY-RBRISTOL MYERS SQUIBB CO | 111,844 | $337.0M | 0.04% | |
| 17 | —EIDOS THERAPEUTICS INC | 3,783 | $217.0M | 0.03% |